Fumonisin B1-13C34
(Synonyms: FB1-13C34) 目录号 : GC52288An internal standard for the quantification of fumonisin B1
Cas No.:1217458-62-2
Sample solution is provided at 25 µL, 10mM.
Fumonisin B1-13C34 (FB1-13C34) is intended for use as an internal standard for the quantification of FB1 by GC- or LC-MS. FB1 is a mycotoxin that has been found in F. moniliforme.1 It inhibits ceramide synthase (IC50 = 0.1 µM for the rat liver enzyme).2 FB1 induces DNA fragmentation and apoptosis in CV-1 cells when used at concentrations of 5 and 25 µM, respectively.3 It is cytotoxic to primary rat hepatocytes and induces hepatocyte nodule formation, a marker of cancer initiation, in rats when administered at a dose of 500 mg/kg for 21 days.4 It has been detected in corn and corn-based foods and livestock feeds.5
1.Gelderblom, W.C.A., Jaskiewicz, K., Marasas, W.F.O., et al.Fumonisins-novel mycotoxins with cancer-promoting activity produced by Fusarium moniliformeAppl. Environ. Microbiol.54(7)1806-1811(1988) 2.Wang, E., Norred, W.P., Bacon, C.W., et al.Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliformeJ. Biol. Chem.266(22)14486-14490(1991) 3.Ciacci-Zanella, J.R., and Jones, C.Fumonisin B1, a mycotoxin contaminant of cereal grains, and inducer of apoptosis via the tumour necrosis factor pathway and caspase activationFood Chem. Toxicol.37(7)703-712(1999) 4.Gelderblom, W.C.A., Cawood, M.E., Snyman, S.D., et al.Structure-activity relationships of fumonisins in short-term carcinogenesis and cytotoxicity assaysFood Chem. Toxicol.31(6)407-414(1993) 5.Bullerman, L.B.Occurrence of Fusarium and fumonisins on food grains and in foodsFumonisins in food27-38(1996)
Cas No. | 1217458-62-2 | SDF | Download SDF |
别名 | FB1-13C34 | ||
Canonical SMILES | O=[13C](O[13C@@H]([13CH2][13C@H]([13CH2][13C@@H]([13CH2][13CH2][13CH2][13CH2][13C@H]([13CH2][13C@@H]([13C@H]([13CH3])N)O)O)O)[13CH3])[13C@@H]([13C@H]([13CH3])[13CH2][13CH2][13CH2][13CH3])O[13C]([13CH2][13C@H]([13C](O)=O)[13CH2][13C](O)=O)=O)[13CH2][13C@H]([13C](O)=O)[13CH2][13C](O)=O | ||
分子式 | [13C]34H59NO15 | 分子量 | 755.6 |
溶解度 | Acetonitrile:Water (1:1): soluble | 储存条件 | -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 1.3235 mL | 6.6173 mL | 13.2345 mL |
5 mM | 0.2647 mL | 1.3235 mL | 2.6469 mL |
10 mM | 0.1323 mL | 0.6617 mL | 1.3235 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >95.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet